Evidence map›Paper›PMID 36548723›Full record

ReviewToxins2022

Current Advances, Research Needs and Gaps in Mycotoxins Biomonitoring under the HBM4EU-Lessons Learned and Future Trends.

Paula Alvito, Ricardo Manuel Assunção, Lola Bajard, Carla Martins, Marcel J B Mengelers, Hans Mol, Sónia Namorado, Annick D van den Brand, Elsa Vasco, Susana Viegas and 1 more

Abstract readReview
In one paragraph

Review in Toxins, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Paula AlvitoNational Institute of Health Dr. Ricardo Jorge (INSA), 1649-016 Lisboa, Portugal.ORCID 0000-0001-8396-1357
Ricardo Manuel AssunçãoNational Institute of Health Dr. Ricardo Jorge (INSA), 1649-016 Lisboa, Portugal.ORCID 0000-0002-4375-0456
Lola BajardRECETOX, Faculty of Science, Masaryk University, Kotlarska 2, 611 37 Brno, Czech Republic.
Carla MartinsNational Institute of Health Dr. Ricardo Jorge (INSA), 1649-016 Lisboa, Portugal.ORCID 0000-0001-7930-2914
Marcel J B MengelersNational Institute for Public Health and the Environment (RIVM), 3720 BA Bilthoven, The Netherlands.
Hans MolWageningen Food Safety Research (WFSR), Part of Wageningen University & Research, 6708 WB Wageningen, The Netherlands.ORCID 0000-0003-0087-6910
Sónia NamoradoNational Institute of Health Dr. Ricardo Jorge (INSA), 1649-016 Lisboa, Portugal.ORCID 0000-0002-7500-8811
Annick D van den BrandNational Institute for Public Health and the Environment (RIVM), 3720 BA Bilthoven, The Netherlands.ORCID 0000-0002-8396-5494
Elsa VascoNational Institute of Health Dr. Ricardo Jorge (INSA), 1649-016 Lisboa, Portugal.ORCID 0000-0001-8532-807X
Susana ViegasNOVA National School of Public Health, NOVA University of Lisbon, 1600-560 Lisbon, Portugal.ORCID 0000-0003-1015-8760
Maria João SilvaNational Institute of Health Dr. Ricardo Jorge (INSA), 1649-016 Lisboa, Portugal.ORCID 0000-0002-6060-0716

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mycotoxins are natural metabolites produced by fungi that contaminate food and feed worldwide. They can pose a threat to human and animal health, mainly causing chronic effects, e.g., immunotoxic and carcinogenic. Due to climate change, an increase in European population exposure to mycotoxins is expected to occur, raising public health concerns. This urges us to assess the current human exposure to mycotoxins in Europe to allow monitoring exposure and prevent future health impacts. The mycotoxins deoxynivalenol (DON) and fumonisin B

Indexed as

MycotoxinsAnimalsBiological MonitoringEuropeFungiHumansRisk AssessmentMycotoxinsdeoxynivalenol (DON)fumonisin B1 (FB1)HBM4EUhuman biomonitoringhuman healthmycotoxins exposurerisk assessment

Identifiers

PMID36548723
PMCPMC9783896

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.